The ST7–MET fusion that couples the first exon of ST7 (suppressor of tumorigenicity 7) is a novel finding in glioblastoma, and has been described as an oncogenic event in non-small-cell lung carcinoma [18] (Figure 3d). This evidence concerns the gene ST7 and non-small cell lung carcinoma.